Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025
07.22.25
Read more
We are leveraging the principle of synthetic lethality to develop medicines that take direct aim at specific tumors. Using an approach that starts and ends with patients, we’re expanding the reach of genetically targeted therapies.